Redwood City, CA, United States of America

Michael Eric Bigler

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2017)
  • Redwood City, CA (US) (2012 - 2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Michael Eric Bigler: Innovator in Antibody Development

Introduction

Michael Eric Bigler is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in immune responses. With a total of 6 patents, his work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

One of his latest patents involves an antibody that binds to human programmed death ligand 2 (PD-L2). This invention provides antibodies and antigen binding fragments, including monoclonal antibodies that specifically target PD-L2. The patent also includes nucleic acids encoding these antibodies and host cells transformed to express them. These antibodies are useful for immunohistochemical detection of PD-L2 expression in tissue samples. Another significant patent focuses on antibodies that bind to human programmed death ligand 1 (PD-L1). This disclosure provides isolated antibodies and their antigen binding fragments, along with kits for detecting complexes of the antibody bound to PD-L1. The antibodies and fragments are valuable for immunohistochemical detection of PD-L1 expression in tissue samples.

Career Highlights

Throughout his career, Michael has worked with notable companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in antibody development and biotechnology.

Collaborations

Michael has collaborated with esteemed colleagues, including Joseph H. Phillips and Linda Liang. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Michael Eric Bigler is a distinguished inventor whose work in antibody development has the potential to advance medical research and therapeutic applications. His innovative patents reflect his commitment to improving healthcare through biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…